The article documents and analyzes patients organizations- and groups of activists’ “evidence-based activismâ€, and the compound dynamic interplay between politics of illness and politics of knowledge it entails in the four condition areas studied: ADHD, Alzheimer, rare diseases...

Highlights the emergence of a "hybrid collective model" of collaboration between patients and experts through a systematic study in the field of rare diseases in France and Portugal, with attention to the reflexive work carried out by patients' organizations on the notion of rareness.

Transcribes a dialogue on the evolution of actor-network theory.

Analyses the role of European patients’ organizations in the process of Europeanization of healthcare policies by exploring the types of organizations constituted by European patients’ organizations and the form of activism they develop.

Examines how groups representing children with Attention Deficit Hyperactivity Disorder (ADHD) in France and Ireland engage within this contested medical domain, and challenges the frequently made association between the process of medicalisation and de-politicisation.

How, and to what extent, do patient organisations renew traditional forms of social participation and protest? This question is examined, drawing on a socio-historical case study of the Association Française contre les Myopathies--French Muscular Dystrophy Organisation (AFM). The originality of...

The past few decades have witnessed the increasingly active participation of patient organisations in research activities concerning them. They contribute substantially to the funding of scientific and clinical research. More importantly, certain patient organisations take strategic decisions...

Provides original sociological research on the development of consumer credit scoring in the United States and its links to subprime mortgage finance.

Presents a case study on the Arizona Stock Exchange, with an emphasis on how exchange automation altered the definition of the market.

Examines the changing roles of science exhibitions from places of 'cold' science, where secure, closed and fixed knowledge is communicated, to places that increasingly engage with 'hot', controversial research and open debates.